Clinical Trial Update: Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of TOP1288 administered rectally in healthy subjects and patients with Ulcerative Colitis; the trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TOP1288

Snippet

Sponsor: Topivert Pharma Ltd | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED